According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings (TTM) are -A$40.94 M. In 2023 the company made an earning of -A$38.02 M an increase over its 2022 earnings that were of -A$0.15 B.The earnings displayed on this page is the company's Pretax Income.